Form 4: Dexcom Executive Michael Jon Brown Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michael Jon Brown, EVP and Chief Legal Officer of Dexcom Inc., sold 8,799 shares of common stock on March 12, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 12, 2024, Michael Jon Brown, the EVP and Chief Legal Officer of Dexcom Inc., sold 8,799 shares of Dexcom's common stock.
- The sale was executed at a price of $134.4107 per share.
- This transaction was mandated by Dexcom's equity incentive plans to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Brown beneficially owns 71,306 shares of Dexcom, which includes 60,303 unvested restricted stock units.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (stock sale for tax obligations) with no inherent positive or negative implications for the company's overall outlook.
Industry Context
Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The sale itself is unlikely to have a significant impact on Dexcom's stock price, as it is a routine transaction.
Key Dates
| Date | Description |
|---|---|
| 03/08/2022 | Grant date for 24,080 restricted stock units that vest through March 8, 2026. |
| 03/08/2023 | Grant date for 14,512 restricted stock units that vest through March 8, 2026. |
| 03/08/2024 | Grant date for 21,711 restricted stock units that vest through March 8, 2027. |
| 03/12/2024 | Date of the stock sale transaction. |
| 03/14/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.